-+ 0.00%
-+ 0.00%
-+ 0.00%

Insights into Cartesian Therapeutics Q4 Earnings

Benzinga·03/09/2026 11:44:07
Listen to the news

Cartesian Therapeutics (NASDAQ:RNAC) just disclosed its Q4 earnings on Monday, March 9, 2026 at 07:00 AM.

Here's a brief overview of the earnings report.

Earnings

Cartesian Therapeutics missed estimated earnings by -73.75%, reporting an EPS of $-1.39 versus an estimate of $-0.8.

Revenue was up $1.71 million from the same period last year.

Overview of Past Earnings

In the previous quarter, the company missed on EPS by $0.68, resulting in a 4.24% increase change in the share price the following day.

Here's a look at Cartesian Therapeutics's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate -0.70 -0.69 -0.61 -0.83
EPS Actual -1.38 0.50 -0.68 -0.40
Revenue Estimate 226K 787K 500K 100K
Revenue Actual 452K 298K 1.10M -759K

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Cartesian Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.